BeStock  
Stocks › Biotechnology › RCUS

Arcus Biosciences RCUS

US equityMarket cap rank #2610Biotechnology
$15.62 −$0.16 (-1.01%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $15.50 -0.77%
Open$15.66
Prev close$15.78
Day range$15.56 – $16.66
Volume1.67M
Market cap$2.25B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

RCUS at a glance

Shares of Arcus Biosciences are down 1.01% at $15.62. The company is worth $2.25B, number 2610 out of 3753 on our list.

It is close to the bottom of its 52-week range ($15.56 to $31.74), 50.8% under the high. Holders are behind 29.2% over twelve months, and down 48.1% across the last three months.

On the chart it has slipped under both the 50-day ($21.47) and 200-day ($24.34) moving averages; RSI is 29, which some call oversold, and the last 30 sessions moved at roughly 83% annualized volatility.

Revenue for the quarter ended Sep 2026 was $9.00M, down 65.4% from a year earlier, and a net loss of $128.00M.

12 analysts follow the stock and the average call is "buy". The mean target, $41.64, sits 166.6% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$15.10 / $20.49
Average price today$15.80
Volume1.67MAvg (90d) 1.66M
Turnover$26.45M
Turnover rate1.56%of shares outstanding
Volume ratio1.16vs. recent average pace
Day amplitude6.97%
Market cap$2.25B
Float market cap$1.67B
Shares outstanding107.19M
EPS (TTM)-$3.29
P/B6.28
Book value / share$2.49
Net profit (TTM)-$473.73M
Net assets$357.96M
30-day volatility83.2%annualized
Avg daily range (ATR)6.45%of price, 14 days
Max drawdown (1y)-50.5%-50.5% from 1y peak

Quote as of Nov 21, 2026 9:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

12 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 11.9 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability3.3
Momentum8.6
Financial health55.4
Analyst view86.8

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$41.64+166.6% vs. current price
Consensus ratingBuy12 analysts covering
Morningstar fair value$29.64Price is below fair value

Wall Street’s average 12-month target is $41.64, 166.6% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $29.64, so shares trade 47.3% below that estimate. On earnings multiple, it sits in the 46th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-1.0%
1 week
-10.4%
1 month
-19.3%
3 months
-48.1%
6 months
-33.3%
Year to date
-34.5%
1 year
-29.2%
Day range
$15.56$16.66
52-week range
$15.56$31.74

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-12.0%Bearish
Price vs 50-day average-27.2%Bearish
Price vs 200-day average-35.8%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)28.6Neutral
MACD (12,26,9)-1.58Bearish
Bollinger band position3%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How RCUS ranks on BeStock

Market value#2599 of 3734
Closeness to 52-week high#3068 of 3724
Dollar volume today#1838 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

RCUS is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on RCUS.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on RCUS

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

RCUS stock: common questions

What is RCUS's latest share price?

$15.62 is the latest print for RCUS, a move of -1.01% against yesterday's close of $15.78. Today's low and high so far: $15.56 and $16.66.

How big is Arcus Biosciences?

Equity value comes to $2.25B at the current price. By that measure it is number 2610 of the 3753 names in our coverage.

Is RCUS near its 52-week high or low?

The year's floor is $15.56 and the ceiling $31.74. Shares are 50.8% away from that ceiling.

Does Arcus Biosciences pay a dividend?

Our data shows no dividend paid by Arcus Biosciences over the trailing twelve months.

Is RCUS rated a buy by Wall Street?

Of 12 analysts, 83% say buy, 17% hold and 0% sell. Price targets average $41.64, with the most cautious at $23.00 and the most optimistic at $50.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on RCUS.

Sign in to join the discussion.

Scroll to Top